GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Payments of Debt

Theragen Etex Co (XKRX:066700) Payments of Debt : ₩-26,925 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Theragen Etex Co Payments of Debt?

Theragen Etex Co's Payments of Debt for the three months ended in Dec. 2024 was ₩-6,076 Mil.

Theragen Etex Co's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-26,925 Mil.

Theragen Etex Co Payments of Debt Historical Data

The historical data trend for Theragen Etex Co's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theragen Etex Co Payments of Debt Chart

Theragen Etex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31,005.89 -7,776.28 -6,283.92 -30,971.75 -26,925.08

Theragen Etex Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27,148.04 -3,007.45 2,765.85 -20,607.54 -6,075.94

Theragen Etex Co Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-26,925 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theragen Etex Co Payments of Debt Related Terms

Thank you for viewing the detailed overview of Theragen Etex Co's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Theragen Etex Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Theragen Etex Co Ltd (XKRX:066700) » Definitions » Payments of Debt
Comparable Companies
XKRX:003120 XKRX:204840 XKRX:009300 XKRX:002800 XKRX:002620 XKRX:054670 XKRX:191420 XKRX:131030 XKRX:002720 XKRX:063160 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
58, Sandan-ro 68-gil, Danwon-gu, Gyeonggi-do, Ansan-si, KOR
Website
http://www.theragenetex.com
Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

Theragen Etex Co Headlines

No Headlines